SELAPRO 45 mg spot-on solution for cats (2.6–7.5 kg)

Țară: Irlanda

Limbă: engleză

Sursă: HPRA (Health Products Regulatory Authority)

Ingredient activ:

Selamectin

Disponibil de la:

Norbrook Laboratories (Ireland) Limited

Codul ATC:

QP54AA05

INN (nume internaţional):

Selamectin

Dozare:

45 mg/pipette

Forma farmaceutică:

Spot-on solution

Tip de prescriptie medicala:

POM: Prescription Only Medicine as defined in relevant national legislation

Zonă Terapeutică:

selamectin

Statutul autorizaţiei:

Authorised

Data de autorizare:

2018-10-26

Caracteristicilor produsului

Health Products Regulatory Authority
29 May 2019
CRN008W44
Page 1 of 6
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
SELAPRO 45 mg spot-on solution for cats (2.6–7.5 kg)
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
​
Each 0.75 ml pipette contains:
​
​
ACTIVE SUBSTANCE:
​
​
Selamectin
45​
mg
​
EXCIPIENTS:
​
​
Butylhydroxytoluene (E321)
0.6 mg​
​
For the full list of excipients, see
section 6.1. ​
3 PHARMACEUTICAL FORM
Spot-on solution.
A clear, colourless to yellow solution.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Cats.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
TREATMENT AND PREVENTION OF FLEA INFESTATIONS caused by
_Ctenocephalides _spp. for one month following a single
administration. This is as a result of the adulticidal, larvicidal and
ovicidal properties of the product. The product is ovicidal for 3
weeks after administration. Through a reduction in the flea
population, monthly treatment of pregnant and lactating animals
will also aid in the prevention of flea infestations in the litter up
to seven weeks of age. The product can be used as part of a
treatment strategy for flea allergy dermatitis and through its
ovicidal and larvicidal action may aid in the control of existing
environmental flea infestations in areas to which the animal has
access.
PREVENTION OF HEARTWORM DISEASE caused by _Dirofilaria immitis _with
monthly administration. Selamectin may be safely
administered to animals infected with adult heartworms, however, it is
recommended, in accordance with good veterinary
practice, that all animals 6 months of age or more living in countries
where a vector exists should be tested for existing adult
heartworm infections before beginning medication with Selamectin. This
product is not effective against adult _D. immitis. _
TREATMENT OF EAR MITES (_Otodectes cynotis_).

Treatment of biting lice infestations _(Felicola subrostratus_)

Treatment of adult roundworms (_Toxocara cati_)

Treatment of adult intestinal hookworms (_An